Bio-Rad Laboratories Inc (BIO)
350.24
-12.96
(-3.57%)
USD |
NYSE |
Nov 14, 16:00
348.23
-2.02
(-0.58%)
After-Hours: 20:00
Bio-Rad Laboratories Research and Development Expense (Quarterly): 91.00M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 91.00M |
| June 30, 2024 | 58.90M |
| March 31, 2024 | 66.38M |
| December 31, 2023 | 63.90M |
| September 30, 2023 | 43.54M |
| June 30, 2023 | 65.04M |
| March 31, 2023 | 74.95M |
| December 31, 2022 | 66.20M |
| September 30, 2022 | 66.81M |
| June 30, 2022 | 64.35M |
| March 31, 2022 | 59.54M |
| December 31, 2021 | 58.85M |
| September 30, 2021 | 64.48M |
| June 30, 2021 | 63.39M |
| March 31, 2021 | 73.91M |
| December 31, 2020 | 56.93M |
| September 30, 2020 | 59.55M |
| June 30, 2020 | 51.98M |
| March 31, 2020 | 49.30M |
| December 31, 2019 | 57.07M |
| September 30, 2019 | 47.94M |
| June 30, 2019 | 50.12M |
| March 31, 2019 | 47.58M |
| December 31, 2018 | 53.07M |
| September 30, 2018 | 49.24M |
| Date | Value |
|---|---|
| June 30, 2018 | 47.45M |
| March 31, 2018 | 49.43M |
| December 31, 2017 | 76.04M |
| September 30, 2017 | 62.08M |
| June 30, 2017 | 62.59M |
| March 31, 2017 | 49.45M |
| December 31, 2016 | 57.39M |
| September 30, 2016 | 49.92M |
| June 30, 2016 | 49.81M |
| March 31, 2016 | 48.59M |
| December 31, 2015 | 55.89M |
| September 30, 2015 | 43.34M |
| June 30, 2015 | 46.55M |
| March 31, 2015 | 47.20M |
| December 31, 2014 | 59.29M |
| September 30, 2014 | 52.79M |
| June 30, 2014 | 55.72M |
| March 31, 2014 | 52.54M |
| December 31, 2013 | 55.85M |
| September 30, 2013 | 52.92M |
| June 30, 2013 | 51.84M |
| March 31, 2013 | 50.34M |
| December 31, 2012 | 58.57M |
| September 30, 2012 | 47.80M |
| June 30, 2012 | 52.34M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
43.54M
Minimum
Sep 2023
91.00M
Maximum
Sep 2024
62.80M
Average
63.64M
Median
Research and Development Expense (Quarterly) Benchmarks
| Agilent Technologies Inc | 127.00M |
| Bruker Corp | 98.10M |
| Azenta Inc | 7.913M |
| Harvard Bioscience Inc | 2.567M |
| Bionano Genomics Inc | 6.831M |